Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism TLR2 antagonists(Toll like receptor 2 antagonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 10 Jul 2018 | |
Arthritis | Preclinical | US | 10 Jul 2018 | |
Encephalomyelitis | Preclinical | US | 10 Jul 2018 |